lysosomal β-glucocerebrosidase 攻击线粒体:对帕金森病治疗的含义
Juan Carlos Rubilar1, Tiago Fleming Outeiro2,3,4,5, Andrés D Klein1
1Centro de Genética y Genómica, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago 7780272, Chile.
Brain : a journal of neurology
|March 4, 2024
概括
帕金森病涉及GBA1基因突变,影响了 lysosomal 和线粒体功能. 这导致有毒蛋白质的积累和细胞死亡,提供新的治疗点,如酶替代和基因疗法.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 细胞生物学 细胞生物学
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,其特征是由于多巴胺能神经元损失导致的运动缺陷.
- 确切的PD的分子原因仍然难以捉摸,尽管包括自-溶酶体功能,α-synuclein聚合和线粒体功能障碍等途径.
研究的目的:
- 阐明GBA1基因及其编码酶β-葡萄糖大脑酶 (GCase) 在帕金森病病因发生过程中的关键作用.
- 审查GCase, lysosomal功能,线粒体健康和PD中的α-synuclein聚合之间的相互作用.
主要方法:
- 对GBA1突变,GCase功能以及它们与PD病理学的联系的现有文献的审查.
- 细胞机制的分析涉及GCase在 lysosomes和线粒体,包括蛋白质聚合和氧化应激.
主要成果:
- GBA1突变会损害GCase的活性,导致溶酶体糖脂积累,破坏自和α-synuclein聚合.
- GCase 功能障碍会产生反循环,加剧 lysosomal 和线粒体损伤,氧化应激和多巴胺细胞死亡.
- 由于突变,GCase在线粒体复合体I完整性中的作用受到损害,增加了对氧化损伤的易感性.
结论:
- GBA1基因和GCase酶在帕金森病的发病过程中通过交织的溶酶体和线粒体通路至关重要.
- 向GCase为帕金森病提供了有前途的治疗途径,包括基因疗法,酶替代和基质减少疗法.
相关概念视频
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
01:15Parkinson's Disease: Overview
544
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
544
01:24Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
01:19Translocation of Proteins into the Mitochondria
3.1K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.1K